Evidence map›Paper›PMID 36945942›Full record

ArticleTurkish journal of medical sciences2023

Decreased circulating microRNA-21 and microRNA-143 are associated to pulmonary hypertension.

Zekeriya Düzgün, Latife Meral Kayıkçıoğlu, Çağdaş Aktan, Buşra Bara, Fatma Zuhal Eroğlu, Burcu Yağmur, Vildan Bozok Çetintaş, Melike Bayındır, Sanem Nalbantgil, Aslı Tetik Vardarli

Open access · bronzeAbstract read
In one paragraph

Article in Turkish journal of medical sciences, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.6field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. MicroRNAs as Biomarkers and Therapeutic Targets in Female Infertility.International journal of molecular sciences · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 2 countries.

Zekeriya DüzgünDepartment of Medical Biology, Faculty of Medicine, Giresun University, Giresun, Turkey.
Latife Meral KayıkçıoğluDepartment of Cardiology, Faculty of Medicine, Ege University, İzmir, Turkey.
Çağdaş AktanDepartment of Medical Biology, Beykent University School of Medicine, İstanbul, Turkey.
Buşra BaraDepartment of Medical Biology, Faculty of Medicine, Ege University, İzmir, Turkey.
Fatma Zuhal EroğluDepartment of Medical Biology, Faculty of Medicine, Ege University, İzmir, Turkey.
Burcu YağmurDepartment of Cardiology, Faculty of Medicine, Ege University, İzmir, Turkey.
Vildan Bozok ÇetintaşDepartment of Medical Biology, Faculty of Medicine, Ege University, İzmir, Turkey.
Melike BayındırDepartment of Medical Biology, Faculty of Medicine, Ege University, İzmir, Turkey.
Sanem NalbantgilDepartment of Cardiology, Faculty of Medicine, Ege University, İzmir, Turkey.
Aslı Tetik VardarliDepartment of Medical Biology, Faculty of Medicine, Ege University, İzmir, Turkey.
Institute of Medical Biology · SGEge University · TRBeykent University · TRGiresun University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPulmonary arterial hypertension (PAH) is characterized by maladaptation of pulmonary vasculature which is leading to right ventricular hypertrophy and heart failure. miRNAs play a crucial role in the regulation of many diseases such as viral infection, cancer, cardiovascular diseases, and pulmonary hypertension (PH). In this study, we aimed to investigate the expression pattern of eight human plasma miRNAs (hsa-miR-21-3p, hsa-miR-143- 3p, hsa-miR-138-5p, hsa-miR-145-3p, hsa-miR-190a, hsa-miR-204-3p, hsamiR-206, hsa-miR-210-3p) in mild-to-severe PH patients and healthy controls.

methods: miRNAs were extracted from the peripheral plasma of the PH patients (n: 44) and healthy individuals (n: 30) by using the miRNA Isolation Kit. cDNA was synthesized using All in-One First strand cDNA Synthesis Kit. Expression of the human plasma hsa-miR- 21-3p, hsa-miR-143-3p, hsa-miR-138-5p, hsa-miR-145-3p, hsa-miR-190a, hsa-miR-204- 3p, hsa-miR-206, hsa-miR210-3p, and miRNAs were analyzed by qRT-PCR.

resultsAccording to our results, in PH patients hsa-miR-21-3p and hsa-miR-143-3p expression levels were decreased by 4.7 and 2.3 times, respectively. No significant changes were detected in hsa-miR-138-5p, hsa-miR-145-3p, hsa-miR-190a, hsa-miR-204-3p, hsamiR-206, and hsa-miR-210-3p expression levels between PH and control groups. In addition, considering the severity of the disease, it was observed that the decrease in miR-138, miR-143, miR-145, miR-190, mir-204, mir-206 and miR-208 expressions was significant in patients with severe PH. DISCUSSION: : In the early diagnosis of PAH, hsa-miR-21-3p and especially hsa-miR-143-3p in peripheral plasma can be considered as potential biomarkers.

Indexed as

Hypertension, PulmonaryAdolescentAdultAgedBiomarkersFemaleGene Expression RegulationHumansMaleMicroRNAsMiddle AgedRNA, CircularYoung AdultBiomarkersMicroRNAsMIRN143 microRNA, humanMIRN21 microRNA, humanRNA, Circularbiomarkerhsa-miR-143-3phsa-miR-21-3pmiRNAPulmonary hypertensionvascular remodeling

Identifiers

PMID36945942
PMCPMC10388131
OpenAlexW4321796034

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.